Envision Pharma Group
PHILADELPHIA, PA / ACCESSWIRE / May 9, 2023 / Envision Pharma Group (Envision) today announced the appointment of Dr. Deepti Sodhi Jaggi to the Envision Board of Directors.
"We are pleased to welcome Deepti to the Envision Board of Directors," shares Meg Heim, CEO of Envision Pharma Group. "Deepti's deep experience in the technology of Artificial Intelligence (AI) and digital therapeutics in the life sciences industry will be invaluable to our mission at Envision as we continue to accelerate our global business expansion and commitment to our clients, and most importantly, impacting patient lives in a positive manner."
Dr. Jaggi's career includes over 20 years of experience in driving innovation at the intersection of life sciences, healthcare, and technology. Her expertise is in transforming businesses through software, AI/ML, and advanced analytics. Most recently, she served as Chief Strategy & Commercial Officer at Better Therapeutics, a publicly held digital therapeutics company. Before that, she served as the Global Head of Patient Insights & Solutions at Astellas Pharmaceuticals with responsibility for the Americas, EMEA, China, and Japan.
Prior to that, Dr. Jaggi served as President & Chief Medical Officer at Clinakos Inc., a Silicon Valley company at the forefront of leveraging data and AI in healthcare and life sciences. She helped grow Clinakos from startup to revenue stage, serving multiple top pharmaceutical companies.
Dr. Jaggi's previous experience includes positions of increasing responsibility and leadership at Johnson & Johnson, Genentech, Oracle, and Kaiser Permanente. She has also served as a consultant to TPG Capital and is a member of the Board of Directors for Technology Credit Union in the San Francisco Bay Area.
"I am thrilled to join the Envision Board at such an exciting time for our industry. I look forward to working with an immensely talented team to accelerate innovation in life sciences through technology and scientific solutions to positively impact patient lives," says Dr. Jaggi.
Dr. Jaggi's educational background includes a PharmD from the University of Southern California and an MBA from Stanford Graduate School of Business.
About Envision Pharma Group
Founded in 2001, Envision Pharma Group is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies, including 18 of the top 20 pharmaceutical companies. Envision supports clients across the product life cycle through a comprehensive suite of services and industry-leading technology solutions that include artificial intelligence and natural language processing, commercialization and integrated strategic consulting, evidence-based scientific communications and engagement, HEOR/market access and data analytics, medical capabilities, and omnichannel solutions. Learn more at www.envisionpharmagroup.com.
Contact Information
Colleen Carter
Associate Director, Communications, Office of the CEO
colleen.carter@envisionpharma.com
1 (508) 505 8856
SOURCE: Envision Pharma Group
To view this piece of content from stats.newswire.com, please give your consent at the top of this page.View source version on accesswire.com:
https://www.accesswire.com/753175/Envision-Pharma-Group-Announces-Appointment-of-Dr-Deepti-Sodhi-Jaggi-to-Board-of-Directors
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
From Manual to Autonomous: Agentic CMS Automates Governance, Compliance, and Content Maintenance14.10.2025 09:00:00 CEST | Press release
Kontent.ai unveils the first CMS built for the AI era - automating governance, compliance, translations, and large-scale updates so teams can focus on creativity and growth. BRNO, CZ / ACCESS Newswire / October 14, 2025 / Across industries, marketing and content teams are being asked to achieve more with fewer resources. Yet expectations for faster publishing, more content and consistency keep rising.AI Agent reviewing thousands of content items AI Agent reviewing entire content repository for specific terms Under that pressure, generative AI has burst onto the scene, reshaping how content is created and discovered. Large language models (LLMs) and generative search experiences are redefining what customers see, hear, and believe about brands. But without structure and governance, AI can easily create more noise than value by diluting tone and introducing compliance risks. Agentic CMS was created to solve this tension. As the world's first agentic content management system, Kontent.ai'
Padcom and General Holdings Sign Term Sheet for USD 55 Million Structured Investment13.10.2025 15:00:00 CEST | Press release
RUSSELL, MB AND DUBAI, UAE, NY / ACCESS Newswire / October 13, 2025 / Potash and Agri Development Corporation of Manitoba Ltd. ("Padcom") and General Holdings Limited ("General Holdings"), a Dubai International Financial Centre (DIFC)-based private investment platform, are pleased to announce the signing of a US$55 million structured investment term sheet. The transaction outlines Padcom's next stage of expansion and General Holdings' continued focus on sustainable industrial and resource-linked investments. The transaction was originated by North Mountain Capital, which introduced the opportunity to General Holdings. Under the term sheet, General Holdings proposes to invest US$18.25 million as a Senior Secured Loan (Tranche 1) and US$36.75 million as Series A Preferred Equity (Tranche 2), with full warrant coverage. The proceeds will be used to expand Padcom's production capacity to 250,000 tonnes per annum of potash and related products, with an intended public listing targeted withi
TripGift(R) Unlocks Glocal Bucket List' Dreams With Launch of New Destination Gift Card SKUs and Marketplaces for Cities, Destinations and Experiences10.10.2025 09:00:00 CEST | Press release
Travel Commerce Innovation Winner delivers New York, Los Angeles, Miami, London, Paris, Dubai, Tokyo Destination Marketplaces and Bucket List Experience Packages in 103 currencies. NEW YORK CITY, NY / ACCESS Newswire / October 10, 2025 / TripGift®, the international multi-award-winning leader in multi-brand, multi-currency closed-loop travel gift cards and digital experience redemption marketplace, today announced the launch of a new line of Bucket List Destination Gift Cards and Marketplaces. Featuring the world's most sought-after cities-New York, London, Paris, Dubai, Tokyo and many more -these gift cards, promo vouchers and marketplaces deliver a unique, flexible and personalized value proposition and destination-themed closed-loop gifting and redemption experience.TripGift Destination Gift Cards Destination Gift cards from TripGift® Leveraging TripGift's recent 'Travel Commerce Innovation of the Year Award' and its robust technology, these personalized gift cards provide truly tar
GSK Unveils Fast-Tracked IBP Transformation with OMP at Gartner Supply Chain Planning Summit9.10.2025 17:00:00 CEST | Press release
ANTWERPEN, BE / ACCESS Newswire / October 9, 2025 / OMP, a leader in supply chain planning solutions, is spotlighting at the Gartner Supply Chain Planning Summit 2025 in London how GSK is accelerating its global transformation. The global healthcare company will reveal how it is reshaping end-to-end planning across its Medicines & Vaccines business. Powered by OMP's AI-driven Unison Planning™, GSK is speeding up demand and supply implementations worldwide. GSK's roadmap to accelerated IBP transformation Tim Shaw, Global Head of Supply Chain Planning CoE at GSK, will share how the company mobilized resources in just four months to reimagine integrated planning. Discover how GSK balanced rapid value delivery with strong IBP foundations, and built a roadmap to accelerate results while ensuring long-term transformation success. The presentation follows an executive session by John Saxby, Senior Vice President, Supply Chain at GSK, offering participants a broader view of the company's IBP j
Laser Digital Partners with Solidus Labs to Advance Crypto-Native Market Surveillance9.10.2025 15:00:00 CEST | Press release
The partnership will equip Laser Digital with Solidus Labs' advanced detection capabilities to monitor trading behavior across exchanges, OTC markets, and DeFi venues Backed by Nomura, Laser Digital was recently licensed by VARA under its Pilot Framework to offer OTC crypto derivatives NEW YORK, NY, NY / ACCESS Newswire / October 9, 2025 / Laser Digital, the digital asset subsidiary of Nomura Group, and Solidus Labs, the category-definer for crypto-native trade surveillance and risk monitoring, today announced a partnership to deliver crypto-native on-chain and off-chain market surveillance. Under this partnership, Solidus Labs will equip Laser Digital with advanced detection capabilities that monitor trading behavior across exchanges, OTC markets, and DeFi venues - reinforcing Laser Digital's risk and compliance operations and supporting evolving regulatory expectations across jurisdictions. Backed by Nomura, one of the world's largest financial institutions, Laser Digital was establi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom